Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases

Published:2021-05-19 Issue:9 Volume:36 Page:1717-1728
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Burckhardt Peter¹^ORCID,Faouzi Mohamed²^ORCID,Buclin Thierry³^ORCID,Lamy Olivier⁴^ORCID,

Affiliation:

1. Clinic Bois Cerf/Hirslanden Lausanne Switzerland

2. University Center for Primary Care and Public Health Biostatistics Lausanne Switzerland

3. University Institute of Clinical Pharmacology Lausanne Switzerland

4. University Hospital CHUV Lausanne Switzerland

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4335

Reference34 articles.

1. Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial

2. Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

3. Observations following discontinuation of long-term denosumab therapy

4. Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study

5. Rebound-associated vertebral fractures after discontinuation of denosumab—from clinic and biomechanics

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One versus 2 years of alendronate following denosumab: the CARD extension;Osteoporosis International;2024-08-07

2. Fracture risk prediction in postmenopausal women with traditional and machine learning models in a nationwide, prospective cohort study in Switzerland with validation in the UK Biobank;Journal of Bone and Mineral Research;2024-06-05

3. Treatment Sequence for Osteoporosis;Endocrine Practice;2024-05

4. On-time denosumab dosing recovered rapidly during the COVID-19 pandemic, yet remains suboptimal;JBMR Plus;2024-03-28

5. Update DVO-Leitlinie 2023 „Prophylaxe, Diagnostik und Therapie der Osteoporose bei postmenopausalen Frauen und bei Männern ab dem 50. Lebensjahr“ – Was ist neu für die Rheumatologie?;Zeitschrift für Rheumatologie;2024-03-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3